Compare ADMA Biologics Inc (ADMA) vs iShares iBoxx $ High Yield Corporate Bond ETF (HYG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs iShares iBoxx $ High Yield Corporate Bond ETF — how do they compare? ADMA Biologics Inc trades at $9.84 (market cap $2.22B), while iShares iBoxx $ High Yield Corporate Bond ETF trades at $79.61. The key difference: iShares iBoxx $ High Yield Corporate Bond ETF is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | HYG | |
|---|---|---|
Market Cap | $2.22B | — |
Sector | Health | Fixed Income |
52-Week High | $20.38 | $81.32 |
52-Week Low | $7.60 | $78.72 |
Enterprise Value | $2.29B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About iShares iBoxx $ High Yield Corporate Bond ETF
HYG is the world's largest high-yield bond ETF, tracking the Markit iBoxx USD Liquid High Yield Index. It provides liquid exposure to non-investment grade corporate debt, with 2026 top holdings including Cloud Software Group and Medline.
Read more on HYG →
